Growth Metrics

Nexalin Technology (NXL) EBITDA Margin (2021 - 2025)

Nexalin Technology (NXL) has 5 years of EBITDA Margin data on record, last reported at 12550.4% in Q3 2025.

  • For Q3 2025, EBITDA Margin fell 575463.0% year-over-year to 12550.4%; the TTM value through Sep 2025 reached 5530.59%, down 208039.0%, while the annual FY2024 figure was 4508.8%, 27809.0% down from the prior year.
  • EBITDA Margin reached 12550.4% in Q3 2025 per NXL's latest filing, down from 2239.01% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 24.83% in Q3 2022 and bottomed at 12550.4% in Q3 2025.
  • Average EBITDA Margin over 5 years is 4154.44%, with a median of 2772.22% recorded in 2021.
  • Peak YoY movement for EBITDA Margin: soared 318305bps in 2022, then plummeted -963584bps in 2023.
  • A 5-year view of EBITDA Margin shows it stood at 3207.88% in 2021, then soared by 46bps to 1744.87% in 2022, then plummeted by -128bps to 3984.16% in 2023, then crashed by -162bps to 10425.19% in 2024, then dropped by -20bps to 12550.4% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 12550.4% in Q3 2025, 2239.01% in Q2 2025, and 4845.81% in Q1 2025.